Industry donated $4.38 bil. worth of medicine and assistance to support healthcare in developing countries over five years, according to a report issued by the International Federation of Pharmaceutical Manufacturers & Associations in December. Over that time, pharma donated health interventions to help as many as 539 mil. people through 126 health partnerships. In a formal validation report on IFPMA's survey, the London School of Economics said that IFPMA's estimate of pharma philanthropy is likely undervalued...
You may also be interested in...
The (virtual) doors closing on the J.P. Morgan Healthcare Conference is the sign for the biopharma industry that the new year has truly started, but before we get too far into 2021, Scrip has taken a look at five of the biggest non-COVID-19 story themes of 2020 in no particular order.
Our graphic tracker of key developments from emergency authorized vaccines, the global roll-out, and late-stage vaccine candidates.
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.